EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Aspergillus fumigatus —a systematic review to inform the World Health Organization priority list of fungal pathogens

C Orla Morrissey iD, Hannah Y Kim iD, Tra-My N Duong iD, Eric Moran iD, Ana Alastruey-Izquierdo iD, David W Denning iD, John R Perfect iD, Marcio Nucci iD, Arunaloke Chakrabarti iD, Volker Rickerts iD, Tom M Chiller iD, Retno Wahyuningsih iD und 6 weitere

Medical Mycology · 27.06.2024 · 62 (6)

DOI: 10.1093/mmy/myad129 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Mycology, online erschienen am 27.06.2024. Verfasst von C Orla Morrissey und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Antifungal Agents, Aspergillosis, World Health Organization. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recognizing the growing global burden of fungal infections, the World Health Organization established a process to develop a priority list of fungal pathogens (FPPL). In this systematic review, we aimed to evaluate the epidemiology and impact of invasive infections caused by Aspergillus fumigatus to inform the first FPPL. The pre-specified criteria of mortality, inpatient care, complications and sequelae, antifungal susceptibility, risk factors, preventability, annual incidence, global distribution, and emergence were used to search for relevant articles between 1 January 2016 and 10 June 2021. Overall, 49 studies were eligible for inclusion. Azole antifungal susceptibility varied according to geographical regions. Voriconazole susceptibility rates of 22.2% were reported from the Netherlands, whereas in Brazil, Korea, India, China, and the UK, voriconazole susceptibility rates were 76%, 94.7%, 96.9%, 98.6%, and 99.7%, respectively. Cross-resistance was common with 85%, 92.8%, and 100% of voriconazole-resistant A. fumigatus isolates also resistant to itraconazole, posaconazole, and isavuconazole, respectively. The incidence of invasive aspergillosis (IA) in patients with acute leukemia was estimated at 5.84/100 patients. Six-week mortality rates in IA cases ranged from 31% to 36%. Azole resistance and hematological malignancy were poor prognostic factors. Twelve-week mortality rates were significantly higher in voriconazole-resistant than in voriconazole-susceptible IA cases (12/22 [54.5%] vs. 27/88 [30.7%]; P = .035), and hematology patients with IA had significantly higher mortality rates compared with solid-malignancy cases who had IA (65/217 [30%] vs. 14/78 [18%]; P = .04). Carefully designed surveillance studies linking laboratory and clinical data are required to better inform future FPPL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillus fumigatusAntifungal AgentsAspergillosisWorld Health OrganizationDrug Resistance, FungalHumansVoriconazoleIncidenceMicrobial Sensitivity TestsInvasive Fungal InfectionsRisk Factors

Stichwörter der Autor:innen

Aspergillus fumigatusepidemiologyincidenceinvasive aspergillosisinvasive fungal diseasemortalityrisk factorssusceptibility

Substanzen

Antifungal AgentsVoriconazole

Autor:innen und Institutionen

  • Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, Australia.
  • The University of Sydney Infectious Diseases Institute (Sydney ID), New South Wales, Australia.
  • Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, New South Wales, Australia.
  • Westmead Hospital, Westmead, New South Wales, Australia.
  • Sinclair Dermatology, East Melbourne, Victoria, Australia.
  • Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

ORCID-Profile: C Orla Morrissey, Hannah Y Kim, Tra-My N Duong, Eric Moran, Ana Alastruey-Izquierdo, David W Denning, John R Perfect, Marcio Nucci, Arunaloke Chakrabarti, Volker Rickerts, Tom M Chiller, Retno Wahyuningsih, Raph L Hamers, Alessandro Cassini, Valeria Gigante, Hatim Sati, Jan-Willem Alffenaar, Justin Beardsley

Förderung

  • World Health Organization
  • Ministry of Education and Science

Zitieren

APA

Morrissey, C. O., Kim, H. Y., Duong, T. N., Moran, E., Alastruey-Izquierdo, A., Denning, D. W., Perfect, J. R., Nucci, M., Chakrabarti, A., Rickerts, V., Chiller, T. M., Wahyuningsih, R., Hamers, R. L., Cassini, A., Gigante, V., Sati, H., Alffenaar, J. W., & Beardsley, J. (2024). Aspergillus fumigatus —a systematic review to inform the World Health Organization priority list of fungal pathogens. Medical Mycology, 62(6). https://doi.org/10.1093/mmy/myad129

Vancouver

Morrissey CO, Kim HY, Duong TN, Moran E, Alastruey-Izquierdo A, Denning DW, et al. Aspergillus fumigatus —a systematic review to inform the World Health Organization priority list of fungal pathogens. Medical Mycology. 2024;62(6). doi:10.1093/mmy/myad129

BibTeX
@article{Morrissey2024,
  author = {Morrissey, C Orla and Kim, Hannah Y and Duong, Tra-My N and Moran, Eric and Alastruey-Izquierdo, Ana and Denning, David W and Perfect, John R and Nucci, Marcio and Chakrabarti, Arunaloke and Rickerts, Volker and Chiller, Tom M and Wahyuningsih, Retno and Hamers, Raph L and Cassini, Alessandro and Gigante, Valeria and Sati, Hatim and Alffenaar, Jan-Willem and Beardsley, Justin},
  title = {Aspergillus fumigatus —a systematic review to inform the World Health Organization priority list of fungal pathogens},
  journal = {Medical Mycology},
  year = {2024},
  volume = {62},
  number = {6},
  doi = {10.1093/mmy/myad129}
}
Kostenlos starten →